DB18700Investigational
TN-201 is a gene therapy comprising a native AAV9 capsid with a genomic cassette containing a cardiomyocyte-specific promoter and the wild-type human MYBPC3 gene.
- Code names
- TN-201
What you can answer from here — as of September 25, 2025
Which companies are running trials of TN-201, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account